Advancing People of Color in Clinical Trials Now: Involvement in Trials Using a Patient-Centered Website: A Community-Engaged Approach

Not Applicable

Completed

Brief Summary: The purpose pf this study is to evaluate the comparative effectiveness of a culturally and linguistically tailored clinical trial literacy website in increasing likelihood of participating in clinical trials. To achieve this objective,a randomized group design will address the following patient-centered outcomes: willingness to enroll in clinical trials and behavioral intent as well as likelihood of referring others to enroll in such trials) before and after exposure to a culturally-tailored clinical trial literacy website. Health literacy will be measured both before and post exposure to tailored messages. Participants will be randomized into two groups. The intervention group (n=50) will have access to culturally tailored website. Participants in the control group (n=50) will have access to NYU 's standard trial participation website.

Detailed Description: Compelling evidence demonstrates racial/ethnic disparities in health and healthcare in the United States. These disparities arise from various factors including unequal access to adequate medical care, perceived racial discrimination, and poor health literacy.The Center for Healthful Behavior Change (CHBC) has been involved in numerous initiatives to eradicate health disparities and have implemented NIH-funded interventions to address inequities in health. Interventions targeting patient-centered outcomes have been suboptimal because of inadequate infrastructure to support equitable contributions from stakeholders (patients, providers, and community leaders) in all aspects of the research process. This is crucial to promote sustainable effects regarding minority patients' ability to make informed decisions about participating in existing clinical trials. This study will address this gap, bringing together academic investigators and important stakeholders to develop a website providing access to culturally tailored videos to enhance awareness of clinical trial, health literacy, thus promoting participation in existing clinical trials.

Recruitment & Eligibility

Inclusion Criteria

Self-reported race/ethnicity as African American, African, Caribbean American or black men and women
accessible by telephone
no plans to move away from the region within the year following enrollment; consent to participate.

Exclusion Criteria

Progressive medical illness in which disability or death is expected within one year
impaired cognitive or functional ability, which would preclude meaningful participation in the study
stated intention to move within the same year of enrollment.

Arm && Interventions

Group	Intervention	Description
Control Group	Standard Website	Participants in the control group will have access to NYU 's standard trial participation website.
Intervention Group	Tailored Website	The intervention group will have access to culturally tailored website.

Primary Outcome Measures

Name	Time	Method
ACTNOW! Clinical Trial Knowledge Assessment Score	Baseline	26 statements involved in assessing the participants' knowledge of clinical trials. The total range of score is 0-104; the higher the score, the higher the level of knowledge.
Clinical Trial Knowledge Assessment Score	Month 3	26 statements involved in assessing the participants' knowledge of clinical trials. The total range of score is 0-104; the higher the score, the higher the level of knowledge.
Self-Efficacy Score	Month 3	A 4-item perceived effectiveness scale, adapted from Fishbein et al. (2002) was used to assess the perceived persuasiveness of the message. The total range of score is 0-16; the higher the score, the higher the level of self-efficacy.
ACTNOW! Self-Efficacy Score	Baseline	A 4-item perceived effectiveness scale was used to assess the perceived persuasiveness of the message. The total range of score is 0-16; the higher the score, the higher the level of self-efficacy.

Secondary Outcome Measures

Name	Time	Method

Locations (1): New York University School of Medicine
🇺🇸
New York, New York, United States